Research suggests that silymarin may help prevent glutathione depletion in the liver, ensuring that the organ remains capable of processing toxins efficiently
Two components contribute to CAI
The mice were anesthetized at 0.5, 1, 2, 4, 8, and 12 h after injection, and the fluorescence distribution was observed and recorded with an in vivo imaging system (Vieworks, Smart-LF, Korean) 60
doi: 10.1007/bf00236072
20% increase in natural GLP-1 level Blood glucose improvement (HbA1c, FBG, HOMA-IR) 24% prediabetic subjects back to normoglycemia PROVEN COMPATIBILITY with Metformin Randomized, Double-blind, Placebo-controlled, Crossover Trial 36 prediabetic subjects (18 - 65 years old) American Diabetes Association (HbA1c = 5.7 - 6.4%) Group A = 250mg Eriomin + 1000mg Metformin Group B = Placebo + 1000mg Metformin Clinically Demonstrated Efficacy Preserve Active GLP-1 Level Active GLP-1 are prone to inactivation by DPP-4 enzymes, inactivated GLP-1 cannot perform its function Effective Glucose Clearance Eriomin group has significant lower blood glucose level at both 60 min and 120 min Eriomin exhibited synergistic effect in combination with metformin , indicating potential for improved efficacy without an increase in adverse effects
